Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreightons Regulatory News (CRL)

Share Price Information for Creightons (CRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 25.00
Bid: 23.00
Ask: 27.00
Change: 0.00 (0.00%)
Spread: 4.00 (17.391%)
Open: 25.00
High: 25.00
Low: 25.00
Prev. Close: 25.00
CRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Replacement: Director/PDMR Shareholding

31 Jul 2023 14:53

RNS Number : 7764H
Creightons PLC
31 July 2023
 

THE FOLLOWING ANNOUNCEMENT REPLACES THE ANNOUNCEMENT "DIRECTOR/PDMR SHAREHOLDING" PUBLISHED AT 11.54 ON 25 JULY 2023 WITH RNS 9815G. IN THAT ANNOUNCEMENT UNDER SECTION 4 OF THE FORM THE ISSUE PRICE PER ORDINARY SHARE WAS GIVEN AS 3 PENCE WHEREAS THE CORRECT PRICE IS 30 PENCE. ALL OTHER TEXT REMAINS THE SAME.

For immediate release 31 July 2023

 

Creightons Plc (the "Company" or "the Group")

Employee Share Option Grant

PDMR/Directors' dealings

Creightons plc (LSE: CRL), manufacturers of personal care, beauty, and fragrance announces that options over 300,000 ordinary 1p shares in the Company have been granted to director Bernard Johnson as part of the Company's policy of providing long-term share-linked and tax-effective incentives to all employees of the Group employees and directors.

These options have been granted under the Company's 2018 Share Option Plan and represent a dilution of 0.5% of the Company's total existing equity. The Board believes this is an effective way of rewarding service and commitment to the Group and to provide on-going incentives to all employees and directors.

The options were issued at 30.00p per ordinary share and can be exercised between the third and tenth anniversary of the 21 July 2023, subject to the option holder's continued employment. No consideration is payable in respect of the grant of these options.

Shareholders will benefit from this grant since it re-enforces the Company's policy of providing long-term share-linked and tax-effective incentives to all our employees.

 Market Abuse Regulation

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

Contacts

Nicholas O'Shea, Creightons plc 01733 281000

Roland Cornish /Felicity Geidt, Beaumont Cornish Limited 0207 628 3396

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail in respect of the Directors subscribing for Director Shares as described above.

 

 

BM Johnson

1

Details  of  th person  dischargin managerial  responsibilitie  person  closely associated

a)

Name

BM Johnson

2

Reason for notification

a)

Position / status

Director

b)

Initial notification

/Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Creightons plc

b)

LEI

213800WROWAJUBGSAJ57

4

Details of the transaction(s): section to be repeated for (i) each type of instrument(ii) each type of transaction; (iii) each date; and (iv) each placwhere transactionhave been conducted

a)

Description  of the financial instrument, type of instrument

Identification code

Options over ordinary shares of 1pence each in Creightons plc

 

ISIN GB0002341666

Nature of the transaction

Award under Employee Share Option Plan

Price(s) and volumes(s)

 

Price(s)

Volumes(s)

Issue price of 30p per ordinary share

300,000

 

d)

Aggregated information

n/a

e)

Date of the transaction

21 July 2023

f)

Place of the transaction

London

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSDUFDFEDSELW
Date   Source Headline
29th Oct 20215:26 pmRNSDirector/PDMR Shareholding
29th Oct 20213:53 pmRNSDirector/PDMR Shareholding
28th Oct 202111:24 amRNSDirector/PDMR Shareholding
22nd Oct 20217:00 amRNSDirector/PDMR Shareholding, Total Voting Rights
21st Oct 20217:00 amRNSDirector/PDMR Shareholding
5th Oct 20213:57 pmRNSDirector/PDMR Shareholding
5th Oct 20213:51 pmRNSDirector/PDMR Shareholding
4th Oct 20219:12 amRNSTotal Voting Rights
30th Sep 20216:29 pmRNSListing Application
27th Sep 20217:00 amRNSAcquisition of Brodie and Stone
20th Sep 20214:41 pmRNSSecond Price Monitoring Extn
20th Sep 20214:36 pmRNSPrice Monitoring Extension
17th Sep 20217:00 amRNSBlock listing Interim Review
3rd Sep 20219:30 amRNSTotal Voting Rights
26th Aug 202111:19 amRNSFinal Dividend Declaration
25th Aug 20211:34 pmRNSResults of AGM, Final Dividend Declaration
4th Aug 20211:47 pmRNSEmma Hardie Ltd - Q&A video available
29th Jul 20217:00 amRNSAcquisition of Emma Hardie Limited and TVR
21st Jul 20212:05 pmRNSSecond Price Monitoring Extn
21st Jul 20212:00 pmRNSPrice Monitoring Extension
21st Jul 202111:05 amRNSSecond Price Monitoring Extn
21st Jul 202111:00 amRNSPrice Monitoring Extension
21st Jul 20219:05 amRNSSecond Price Monitoring Extn
21st Jul 20219:00 amRNSPrice Monitoring Extension
21st Jul 20217:00 amRNSPreliminary Results - for year ended 31 March 2021
20th Jul 20214:17 pmRNSNotice of Results and Presentation
6th Jul 20213:24 pmRNSUpdate on Notice of Final Results
24th Jun 20217:00 amRNSPresentation on Final Results
26th Mar 202111:35 amRNSChange of Director's Role
18th Mar 20217:00 amRNSBlock Listing Six Monthly Review
16th Mar 202111:42 amRNSShare Option Grant
9th Mar 20219:52 amRNSDirector/PDMR Shareholding
25th Feb 20212:54 pmRNSDirector/PDMR Shareholding
24th Feb 20215:28 pmRNSFurther Statement regarding Innovaderma
24th Feb 20214:46 pmRNSForm 8.3 - Creightons PLC
12th Feb 20212:35 pmRNSForm 8.3 - Creightons
11th Feb 20218:43 amRNSForm 8 (OPD) Creightons plc
5th Feb 20215:15 pmRNSForm 8.3 - Creightons plc
4th Feb 20216:28 pmRNSRule 2.9 Announcement
4th Feb 20215:37 pmRNSForm 8 (OPD) CREIGHTONS
3rd Feb 202112:14 pmGNWForm 8.3 - [Creightons plc] - Opening Disclosure - (CGWL)
2nd Feb 202111:41 amRNSStatement re Possible Offer
2nd Feb 20217:00 amRNSStatement regarding Innovaderma plc
9th Dec 20207:00 amRNSHalf-year Report
24th Nov 20209:28 amRNSChange of Auditor
24th Nov 20209:19 amRNSInterim Results Presentation
30th Sep 20205:39 pmRNSResult of AGM
18th Sep 202011:37 amRNSBlock listing Interim Review
16th Sep 202011:49 amRNSHolding(s) in Company
8th Sep 20205:47 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.